tiprankstipranks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR

Monopar Therapeutics Inc (MNPR) Stock Investors

333 Followers
Based on 747,498 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold MNPR
On average, investors allocate 0.00% of their portfolios to MNPR
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,498 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding MNPR

2.1%
Last 7
Days
2.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding MNPR, out of 747,498 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

MNPR Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,196 investors who made their portfolios public
The table shows changes in MNPR in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

MNPR Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ChargePoint Holdings
4.18%
-1.24%
-2.42%
833.60M
Consumer Cyclical
Merck & Company
3.90%
-0.83%
+3.36%
318.55B
Healthcare
Coherus Biosciences
2.57%
-1.69%
-5.36%
188.15M
Healthcare
DraftKings
5.81%
-1.05%
-1.92%
32.41B
Consumer Cyclical
Blink Charging Co
5.22%
-1.56%
-4.77%
315.31M
Industrials
Plug Power
5.01%
-1.43%
-3.20%
1.87B
Industrials
Assertio Therapeutics
2.90%
-1.69%
-5.26%
156.00M
Healthcare
XPeng, Inc. ADR
5.34%
-1.58%
-3.82%
7.82B
Consumer Cyclical
AMC Entertainment
5.73%
-1.39%
-4.00%
1.48B
Communication Services
Bristol-Myers Squibb
3.23%
-1.04%
+1.34%
86.44B
Healthcare
Based on the activity of 747,498 active portfolios
Open your Smart Portfolio

MNPR Investor Analysis

MNPR investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
18.0%
of MNPR holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
MNPR investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
52.5%
of MNPR holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
MNPR investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
29.5%
of MNPR holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of MNPR stock investors
See who invests in MNPR according to age group and performance.

FAQ

How many retail Investors hold MNPR?
<0.1% of TipRanks' retail investors hold MNPR in their portfolios.
    What is MNPR Investor Sentiment?
    MNPR’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of MNPR in the last 7 days?
      ▲ 2.1% of TipRanks' retail investors changed their holding of MNPR in the last 7 days.
        What percentage of retail investors changed their holding of MNPR in the last 30 days?
        ▼ 2.0% of TipRanks' retail investors changed their holding of MNPR in the last 30 days.
          What is the average age of retail investors who hold MNPR?
          The average age of MNPR Holders is between 35–55.
            What other stocks have MNPR investors also bought?
            MNPR Investors also bought CHPT, MRK, CHRS, DKNG, BLNK, PLUG, ASRT, XPEV, AMC, BMY.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              DHRDanaher
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis